Liu Yuhui, Yeh Nancy, Zhu Xin-Hua, Leversha Margaret, Cordon-Cardo Carlos, Ghossein Ronald, Singh Bhuvanesh, Holland Eric, Koff Andrew
Department of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
EMBO J. 2007 Nov 14;26(22):4683-93. doi: 10.1038/sj.emboj.7601886. Epub 2007 Oct 18.
How proteins participate in tumorigenesis can be obscured by their multifunctional nature. For example, depending on the cellular context, the cdk inhibitors can affect cell proliferation, cell motility, apoptosis, receptor tyrosine kinase signaling, and transcription. Thus, to determine how a protein contributes to tumorigenesis, we need to evaluate which functions are required in the developing tumor. Here we demonstrate that the RCAS/TvA system, originally developed to introduce oncogenes into somatic cells of mice, can be adapted to allow us to define the contribution that different functional domains make to tumor development. Studying the development of growth-factor-induced oligodendroglioma, we identified a critical role for the Cy elements in p21, and we showed that cyclin D1T286A, which accumulates in the nucleus of p21-deficient cells and binds to cdk4, could bypass the requirement for p21 during tumor development. These genetic results suggest that p21 acts through the cyclin D1-cdk4 complex to support tumor growth, and establish the utility of using a somatic cell modeling system for defining the contribution proteins make to tumor development.
蛋白质的多功能性质可能会掩盖其在肿瘤发生过程中的参与方式。例如,根据细胞环境的不同,细胞周期蛋白依赖性激酶(cdk)抑制剂可以影响细胞增殖、细胞运动、细胞凋亡、受体酪氨酸激酶信号传导和转录。因此,要确定一种蛋白质如何促进肿瘤发生,我们需要评估在肿瘤发生过程中哪些功能是必需的。在这里,我们证明了最初用于将癌基因导入小鼠体细胞的RCAS/TvA系统,可以进行改造,以便我们确定不同功能域对肿瘤发展的贡献。通过研究生长因子诱导的少突胶质细胞瘤的发展过程,我们确定了p21中Cy元件的关键作用,并且我们发现,在p21缺陷细胞的细胞核中积累并与cdk4结合的细胞周期蛋白D1T286A,在肿瘤发展过程中可以绕过对p21的需求。这些遗传学结果表明,p21通过细胞周期蛋白D1-cdk4复合物发挥作用以支持肿瘤生长,并确立了使用体细胞建模系统来确定蛋白质对肿瘤发展贡献的实用性。